Evidence map›Paper›PMID 27062392›Full record

ArticleBrain pathology (Zurich, Switzerland)2017

Common Impact of Chronic Kidney Disease and Brain Microhemorrhages on Cerebral Aβ Pathology in SHRSP.

Daniel Pirici, Luiza Stanaszek, Cornelia Garz, Solveig Niklass, Hans-Jochen Heinze, Thomas Kalinski, Johannes Attems, Stefanie Schreiber

Open access · bronzeAbstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Association of impaired kidney function with dementia and brain pathologies: A community-based cohort study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Daniel PiriciDepartment of Research Methodology, University of Medicine and Pharmacy of Craiova, Petru Rares Street 2, Craiova, 200349, Romania.
Luiza StanaszekGerman Center for Neurodegenerative Diseases (DZNE), Leipziger Strasse 44, Magdeburg, 39120, Germany.
Cornelia GarzGerman Center for Neurodegenerative Diseases (DZNE), Leipziger Strasse 44, Magdeburg, 39120, Germany.
Solveig NiklassGerman Center for Neurodegenerative Diseases (DZNE), Leipziger Strasse 44, Magdeburg, 39120, Germany.
Hans-Jochen HeinzeGerman Center for Neurodegenerative Diseases (DZNE), Leipziger Strasse 44, Magdeburg, 39120, Germany.
Thomas KalinskiDepartment of Pathology, Otto-von-Guericke University, Leipziger Strasse 44, Magdeburg, 39120, Germany.
Johannes AttemsCampus for Ageing and Vitality, Institute of Neuroscience and Newcastle University Institute for Ageing, Newcastle upon Tyne, NE4 5PL, UK.
Stefanie SchreiberGerman Center for Neurodegenerative Diseases (DZNE), Leipziger Strasse 44, Magdeburg, 39120, Germany.
Otto-von-Guericke University Magdeburg · DEMossakowski Medical Research Institute, Polish Academy of Sciences · PLNewcastle Hospitals - Campus for Ageing and Vitality · GBUniversity of Medicine and Pharmacy of Craiova · RO

Funding

Medical Research Council G0400074Medical Research Council G0502157Medical Research Council G0900652Medical Research Council G1100540
6 · The paper itself

Abstract

While chronic kidney disease seems to be an independent risk factor for cognitive decline, its impact on cerebral amyloid-β (Aβ) depositions, one hallmark of Alzheimer's Disease (AD) pathology, has not been investigated. Utilizing 80 male nontransgenic spontaneously hypertensive stroke prone rats (SHRSP) at various ages (12 to 44 weeks), tubulointerstitial renal damage, prevalence of cerebral microhemorrhages and Aβ accumulations were quantified. Using age-adjusted general linear models we investigated the main and interaction effects of renal damage and cerebral microhemorrhages on cerebral Aβ load. In addition, using post mortem human brain tissue of 16 stroke patients we examined the co-localization of perivascular Aβ deposits and small vessel wall damage. Statistical models revealed an age-independent main effect of tubulointerstitial kidney damage on brain Aβ accumulations, which was reinforced by the consecutive presence of cerebral microhemorrhages. Moreover, cerebral microhemorrhages independently predicted brain Aβ burden in SHRSP. In up to 69% of all human cases perivascular Aβ deposits were detected in the direct vicinity of small vessel wall damage. Our results support the associations between vascular pathology and Aβ deposition, and demonstrate a relationship between chronic kidney disease and cerebral Aβ pathology. Hence, our data suggest that prevention of chronic renal damage may reduce cerebral Aβ pathology.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsBrainCerebral Amyloid AngiopathyCerebral Small Vessel DiseasesDisease Models, AnimalHumansKidneyMaleRatsRats, Inbred SHRRenal Insufficiency, ChronicAmyloid beta-Peptidesamyloid βcerebral small vessel diseasechronic kidney diseasemicrohemorrhagesSHRSPtwo hit vascular hypothesis of AD

Identifiers

PMID27062392
PMCPMC8029023
OpenAlexW2339184894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.